BioSpace News Archive

Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased to announce that it has successfully completed the requirements for certification of its quality management system under the new Medical Device Regulation now in force in the European Union.

At the 2022 annual meeting of the American Association of Orthopedic Surgeons, Konica Minolta Healthcare Americas, Inc. will showcase its broad array of orthopedic and musculoskeletal imaging and information management solutions, including the award-winning Dynamic Digital Radiography technology.

Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 26, 2022, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results.

Pionyr Immunotherapeutics, Inc., a company developing first-in-class Myeloid TuningTM antibody therapeutics that enhance the body’s antitumor immunity by altering, or “tuning”, immune cells within the tumor microenvironment, announced today preclinical results from its PY265 program demonstrating efficacy both as single-agent and in combination with anti-PD1.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has advanced VX-147 into pivotal development for people living with proteinuric kidney disease mediated by two mutations in the APOL1 gene (AMKD), which affects approximately 100,000 people in the U.S. and Europe.

Peptilogics will present three papers at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting in Chicago March 24.

The Placement is to accredited investors of up to a total of $4 million, by issuance of up to 80 Convertible Loan Notes, each with a face value of $50,000.

CinCor Pharma, Inc. (NASDAQ: CINC) today announced financial results for the fourth quarter and full-year ended December 31, 2021 and provided a corporate update.

Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M. Reynolds to the Psychemedics Board of Directors effective April 4th, 2022.

Sharps Compliance Corp., a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, announced that it has entered into a new $36.0 million credit facility with a commercial bank.